by Fabio Giuseppe Carlo Carisio for VT Italy

US President Donald Trump revealed Friday that Gilead Sciences’ antiviral drug Remdesivir has been cleared by the Food and Drug Administration (FDA) for the treatment of COVID-19.

According to Reuters, Gilead CEO Daniel O’Day called the FDA’s emergency authorization an “important first step” and pledged to donate “1 million vials of Remdesivir.” US Vice President Mike Pence also said that 1 million vials of Remdesivir will be distributed to hospitals starting Monday.

The FDA authorization comes just two days after Gilead Sciences revealed it was aware of “positive data” from a clinical trial by the US National Institute of Allergy and Infectious Diseases of the antiviral drug as a COVID-19 treatment.

The institute is led by Anthony Fauci, one of the leading doctors assigned to the White House Coronavirus Task Force. During a Wednesday meeting in the Oval Office, Fauci indicated that the drug trial showed that Remdesivir has had a significant effect on reducing coronavirus symptoms.

Read Full Article

ATTENTION READERS

We See The World From All Sides and Want YOU To Be Fully Informed
In fact, intentional disinformation is a disgraceful scourge in media today. So to assuage any possible errant incorrect information posted herein, we strongly encourage you to seek corroboration from other non-VT sources before forming an educated opinion.

About VT - Policies & Disclosures - Comment Policy
Due to the nature of uncensored content posted by VT's fully independent international writers, VT cannot guarantee absolute validity. All content is owned by the author exclusively. Expressed opinions are NOT necessarily the views of VT, other authors, affiliates, advertisers, sponsors, partners, or technicians. Some content may be satirical in nature. All images are the full responsibility of the article author and NOT VT.